Pet Drug Reports

Thiabendazole: adverse event reports in all combinations

Active ingredient, alone and in combinations

Brand names with this ingredient: Tresaderm Dermatologic, Equivet-14, Equizole-B.

The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand.

Read this first. FDA says this about the data:

An API dataset query result cannot be used to estimate the risk associated with the product or compare one drug or device product with another. When looking at the results, be aware that there is no certainty that the reported drug or device caused the adverse event. This dataset should not be the sole source of information for clinical decision-making or other assumptions about the safety or effectiveness of a product. The adverse event may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources.

FDA Center for Veterinary Medicine publishes these words. Source: Adverse Event Reports for Animal Drugs and Devices, read on . The data have the reports that FDA received through .

This page is not veterinary advice. For an animal that is ill, speak to a veterinarian.

Contacting a veterinarianHow to report to FDA

FDA reports received through . Counts include this ingredient alone and in combinations. Why brand names have no separate count.

From January 1987 to June 2026, FDA received 2,098 adverse event reports that name a drug with thiabendazole, alone or in a combination. 3 sets of active ingredients with thiabendazole have a drug page.

Of the 2,098 reports, 813 (38.8%) are about cats. 668 reports are about dogs (31.8%). In January to March 2026, FDA received 70 reports that name thiabendazole, alone or in a combination. The signs that appear in the largest number of the 2,098 reports are "Lethargy", "Vomiting" and "Accidental exposure". A report is not proof that a drug caused a sign.

Reports that name this ingredient rose by 25.5% in the 12 months to June 2026, compared with the 12 months before. Reports for all animal drugs fell by 4.6% in the same periods. The newest months can get more reports in a later update. Reports about dogs are 31.8% of the reports that name this ingredient, and 72.6% of all reports.

Reports in the latest closed quarter

Reports that name thiabendazole, by the quarter in which FDA received them
SpeciesJan to Mar 2026Oct to Dec 2025Jan to Mar 2025
All species706633
Dog6152
Cat444524
Horse000
Other or not given2067

January to March 2026 is the latest closed quarter in the data.

All updatesFeed of updates (RSS)

Drug pages with thiabendazole

A report names a drug by its set of active ingredients. Each set with thiabendazole that has a drug page is in the table, in order of name. The table has 3 sets.

Drug pages with thiabendazole, in order of name, with the reports of each page
Active ingredientsReports, all yearsReports, latest 12 months
Dexamethasone + Neomycin Sulfate + Thiabendazole1,137174
Dexamethasone + Thiabendazole90417
Thiabendazole560

A report can name more than one set, so the counts of the sets can add to more than the count of the page.

An API dataset query result cannot be used to estimate the risk associated with the product or compare one drug or device product with another.

FDA Center for Veterinary Medicine. Source: Adverse Event Reports for Animal Drugs and Devices

Signs that the reports list

A sign is a coded term from the report. The words in brackets are a plain gloss of the term. The percentage is the share of the 2,098 reports that list the sign. One report can list more than one sign and more than one drug.

The sign that is in the largest number of the reports comes first.

  1. Lethargy[unusually tired or inactive]11.4%239 reports
  2. Vomiting8.4%176 reports
  3. Accidental exposure[exposure that was not intended]8.1%170 reports
  4. Eye irritation6.5%136 reports
  5. Unclassifiable adverse event[event that fits no dictionary term]5.4%114 reports
  6. Anorexia[not eating]5.3%112 reports
  7. Ataxia[unsteady, uncoordinated movement]4.9%102 reports
  8. Elevated alanine aminotransferase (ALT)[a liver enzyme above the normal range]4.6%96 reports
  9. Deafness4.5%95 reports
  10. Lack of efficacy - NOS[the product did not have the expected effect]4.4%93 reports
  11. Dispenser, Abnormal[a product quality report, not a sign in an animal]4.1%85 reports
  12. Not eating4%83 reports
  13. Pinnal erythema3.2%68 reports
  14. Vials, Damaged[a product quality report, not a sign in an animal]3.2%67 reports
Show the next 16 signs
  1. Other abnormal test result NOS[abnormal laboratory result, type not specified]3.1%66 reports
  2. Behavioural disorder NOS[behaviour change, type not specified]3.1%65 reports
  3. Eye pain3.1%65 reports
  4. Weight loss3.1%64 reports
  5. Diarrhoea[diarrhea]3%63 reports
  6. Death by euthanasia[the animal was euthanized]2.9%60 reports
  7. Containers, Abnormal[a product quality report, not a sign in an animal]2.8%59 reports
  8. Death2.6%54 reports
  9. Decreased appetite2.6%54 reports
  10. Elevated total bilirubin[bilirubin above the normal range]2.5%52 reports
  11. Depression[dull, quiet or withdrawn]2.2%47 reports
  12. Fever2.2%47 reports
  13. Vocalisation[crying out or unusual noise]2.1%44 reports
  14. Containers, Leaking[a product quality report, not a sign in an animal]2%43 reports
  15. Pruritus[itching]2%43 reports
  16. Closure, Abnormal[a product quality report, not a sign in an animal]2%42 reports

Download all signs (CSV)

Reports by species

Reports for each month, Jul 2021 to Jun 2026

Dog103 reports. Largest count in one month: 6 (Apr 2022)
Cat399 reports. Largest count in one month: 16 (Aug 2024)
Horse0 reports

No chart: no month has 5 or more reports.

Other or not given134 reports. Largest count in one month: 10 (Jan 2026)

The month is the month in which FDA received the report. Each chart has its own scale. FDA says that a report can take 3 to 6 months to reach the public data. The newest months can get more reports in a later update.

Reports by year

  • Dog
  • Cat
  • Horse
  • Other or not given
Reports that name thiabendazole, by the year in which FDA received them and by species
YearDogCatHorseOther or not givenAll species
2026125802898
202528121022171
20242191019131
202394902583
20222159028108
20212858020106
20205046030126
20194157035133
20184538039122
2017343201682
2016212101254
201518120131
201416100127
201324120238
201230120143
2011441301875
2010311903686
2009321702372
2008251803174
20072413097134
2006251004479
200521902959
200420903362
200317901642
2002570517
20011020012
200042006
1999450110
199820002
199710001
199631015
199210001
199100011
199000011
198902013
198711013

2026 has the reports that FDA received through Jun 2026. Download the years (CSV)

What the reports record

Outcome at the time of the report

  • Recovered/Normal11.9%250
  • Recovered with Sequela[recovered, with a lasting effect]0.4%8
  • Ongoing12.3%258
  • Died3.1%64
  • Euthanized2.6%55
  • Outcome Unknown26.7%560

An outcome in a report is not proof that the drug caused it. The person who sends the report gives the outcome. Each share is of the 2,098 reports that name thiabendazole.

Kind of report

  • Safety issue74%1,552
  • Lack of expected effectiveness2.1%45
  • Both safety and lack of expected effectiveness3.7%77
  • Manufacturing or product defect20.1%421
  • Other0.1%3

Age of the animal

  • Under 1 year9.3%195
  • 1 to 3 years13.6%285
  • 4 to 7 years15.3%322
  • 8 to 11 years15.6%328
  • 12 years and over16.1%338
  • Age not given30%630

Each share of kind and age is of the 2,098 reports that name thiabendazole.

Approved animal drugs with this active ingredient (FDA Green Book)

This section is reference data. It has no report count.

The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand.

Brand names

  • Tresaderm Dermatologic
  • Equivet-14
  • Equizole-B

What the Green Book records give

Applications with an approval in force
3
Approved species
Cats, Dogs, Equids
Dose forms
Liquid, Liquid (Solution), Solution
Routes
Nasogastric, Oral, Topical
Sale
RX (prescription)
Earliest approval date in the records

The species, dose forms and routes are the words of the Green Book records for all the applications together. One product can have fewer. The label of a product gives its approved use.

Applications in the Green Book of 2 Nov 2026, pioneer applications (NADA) first
Brand nameActive ingredientsSponsorApproved speciesApplication
Tresaderm Dermatologic SolutionDexamethasone, Neomycin Sulfate, ThiabendazoleBoehringer Ingelheim Animal Health USA, Inc.Dogs, CatsNADA 042-633
Equivet-14; Equizole-BThiabendazole, TrichlorfonFarnam Companies, Inc.HorsesNADA 091-067
Thiabendazole, Dexamethasone, Neomycin Sulfate SolutionDexamethasone, Neomycin Sulfate, ThiabendazoleDechra Veterinary Products LLCDogs, CatsANADA 200-565
Thibenzole Sheep & Goat Wormerapproval withdrawnThiabendazoleBoehringer Ingelheim Animal Health USA Inc.Sheep, GoatsNADA 013-022
Equizole Horse Wormerapproval withdrawnThiabendazoleBoehringer Ingelheim Animal Health USA Inc.HorsesNADA 013-407
Thibenzole 20% Swine Premixapproval withdrawnThiabendazoleBoehringer Ingelheim Animal Health USA Inc.SwineNADA 013-954
Omnizoleapproval withdrawnThiabendazoleBoehringer Ingelheim Animal Health USA Inc.Cattle, Sheep, GoatsNADA 014-350
TBZ Cattle Wormer (Drench)approval withdrawnThiabendazoleBoehringer Ingelheim Animal Health USA Inc.CattleNADA 015-123
TBZ 200 Medicated Feed Premixapproval withdrawnThiabendazoleBoehringer Ingelheim Animal Health USA Inc.Cattle, Swine, Sheep, GoatsNADA 015-875
Thibenzole (18 mg)approval withdrawnThiabendazoleBoehringer Ingelheim Animal Health USA Inc.CattleNADA 030-103
E-Z-EX Wormer Pelletsapproval withdrawnThiabendazoleADM Animal NutritionCattle, Sheep, GoatsNADA 030-578
Equizoleapproval withdrawnThiabendazoleBoehringer Ingelheim Animal Health USA Inc.Horses, Cattle, Sheep, GoatsNADA 034-114
Thibenzole Pig Wormerapproval withdrawnThiabendazoleBoehringer Ingelheim Animal Health USA Inc.SwineNADA 035-631
Equizole Aapproval withdrawnPiperazine Phosphate, ThiabendazoleBoehringer Ingelheim Animal Health USA Inc.HorsesNADA 037-410
Purina Horse Wormer Medicatedapproval withdrawnThiabendazoleVirbac AH, Inc.HorsesNADA 040-205
E-Z-EX Wormer Mintrate Blockapproval withdrawnThiabendazoleADM Animal NutritionCattleNADA 042-910
Thibenzole 300 Medicatedapproval withdrawnThiabendazoleBoehringer Ingelheim Animal Health USA Inc.CattleNADA 043-141
Equizole Horse Wormer Pelletsapproval withdrawnThiabendazoleBoehringer Ingelheim Animal Health USA Inc.HorsesNADA 044-654
Equizole A Liquidapproval withdrawnPiperazine Citrate, ThiabendazoleBoehringer Ingelheim Animal Health USA Inc.HorsesNADA 047-333
TBZ Wormer Paste 50%approval withdrawnThiabendazoleBoehringer Ingelheim Animal Health USA Inc.CattleNADA 048-487
TBZ Wormer Paste 43%approval withdrawnThiabendazoleBoehringer Ingelheim Animal Health USA Inc.CattleNADA 049-461
Equizole 50% Wormer Paste; Equizole 50% Wormer Paste For Horsesapproval withdrawnThiabendazoleBoehringer Ingelheim Animal Health USA Inc.HorsesNADA 098-689

FDA pages for this ingredient

The site checked these addresses on . The links open in a new tab.

Cite this page

Pet Drug Reports. Thiabendazole, all combinations: adverse event reports that FDA received. https://petdrugreports.com/ingredient/thiabendazole/ Source: FDA Center for Veterinary Medicine, openFDA Animal and Veterinary adverse event reports, export of . Reports received through .

Embed this card on your site

Copy this code into your page. The card shows the figures above with their source. A line under the card links to this page.

How embedding works. It is free. Keep the link in the card and the link line under it.

Where the data come from

The counts come from the openFDA Animal and Veterinary adverse event files, export of 30 Oct 2026. The files have the reports that the FDA Center for Veterinary Medicine received through 26 Jun 2026. The files mask brand and manufacturer names. The site counts a drug by the active ingredients that each record gives, and gives no count to a brand, an application or a company. Ingredient names and the lists of approved products follow the FDA Green Book of 2 Nov 2026. Ingredient names follow the Green Book, with salts and forms as FDA lists them.

The site does not publish report text, lot numbers or details of a reporter. FDA's record is the authority. See how the site counts reports, the data sources and the corrections page.

Questions about these reports

Which brand are these reports about?

The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand. The Green Book section of this page lists brand names with this active ingredient.

Do the reports show that the ingredient caused the signs?

No. A report can name more than one drug, and a drug can have more than one active ingredient. FDA states this about the data.

When looking at the results, be aware that there is no certainty that the reported drug or device caused the adverse event.

The adverse event may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources.

FDA Center for Veterinary Medicine. Source: Adverse Event Reports for Animal Drugs and Devices

How many reports did FDA receive in the latest 12 months?

FDA received 192 reports in the 12 months to June 2026. It received 153 reports in the 12 months before. FDA says that a report can take 3 to 6 months to reach the public data. The newest months can get more reports in a later update.

What kinds of report are in the count?

Of the 2,098 reports received from January 1987 to June 2026, 74% are about a safety issue only. 5.8% are about a lack of expected effectiveness, alone or with a safety issue. 20.1% are about a defect of the product or its package.